Cargando…

Endpoints in stem cell trials in ischemic heart failure

Despite multimodal regimens and diverse treatment options alleviating disease symptoms, morbidity and mortality associated with advanced ischemic heart failure remain high. Recently, technological innovation has led to the development of regenerative therapeutic interventions aimed at halting or rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banovic, Marko, Loncar, Zlatibor, Behfar, Atta, Vanderheyden, Marc, Beleslin, Branko, Zeiher, Andreas, Metra, Marco, Terzic, Andre, Bartunek, Jozef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552990/ https://www.ncbi.nlm.nih.gov/pubmed/26319401 http://dx.doi.org/10.1186/s13287-015-0143-9

Ejemplares similares

Mass Customized Outlook for Regenerative Heart Failure Care
por: Yamada, Satsuki, et al.
Publicado: (2021)

Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy
por: Yamada, Satsuki, et al.
Publicado: (2019)

Integrate and boost: bioscaffolds nurture the cardiac regenerative paradigm
por: Bartunek, Jozef, et al.
Publicado: (2015)

Regenerative heart failure therapy headed for optimization
por: Terzic, Andre, et al.
Publicado: (2014)

Clinical development plan for regenerative therapy in heart failure
por: Terzic, Andre, et al.
Publicado: (2016)

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design
por: Bartunek, Jozef, et al.
Publicado: (2015)

Novel device-based interventional strategies for advanced heart failure
por: Toth, Gabor G., et al.
Publicado: (2016)

Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure
por: Bartunek, Jozef, et al.
Publicado: (2023)

Screening for regenerative therapy responders in heart failure
por: Yamada, Satsuki, et al.
Publicado: (2021)

Challenges in Diagnosis and Functional Assessment of Coronary Artery Disease in Patients With Severe Aortic Stenosis
por: Aleksandric, Srdjan, et al.
Publicado: (2022)

Novel IVC Doraya Catheter Provides Congestion Relief in Patients With Acute Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2022)

Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes
por: Bartunek, Jozef, et al.
Publicado: (2020)

Safety, Feasibility of Controllable Decrease of Vena Cava Pressure by Doraya Catheter in Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2023)

Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure
por: Banovic, Marko, et al.
Publicado: (2022)

Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome
por: Arrell, D. Kent, et al.
Publicado: (2021)

Reparative resynchronization in ischemic heart failure: an emerging strategy
por: Yamada, Satsuki, et al.
Publicado: (2014)

Aortic thoracic neuromodulation in heart failure with preserved ejection fraction
por: Paolisso, Pasquale, et al.
Publicado: (2022)

Genomic chart guiding embryonic stem cell cardiopoiesis
por: Faustino, Randolph S, et al.
Publicado: (2008)

Circulating SERPINA3 improves prognostic stratification in patients with a de novo or worsened heart failure
por: Delrue, Leen, et al.
Publicado: (2021)

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity
por: Robinson, Emma L., et al.
Publicado: (2023)

Utilizing longitudinal data in assessing all‐cause mortality in patients hospitalized with heart failure
por: Herman, Robert, et al.
Publicado: (2022)

Asymptomatic Severe and Moderate Aortic Stenosis: Time for Appraisal of Treatment Indications
por: Banovic, Marko, et al.
Publicado: (2023)

Mitral Valve Repair of Atrial Functional Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction
por: Balogh, Zsuzsanna, et al.
Publicado: (2020)

Endpoints in Heart Failure Drug Development
por: Hussain, Aliza, et al.
Publicado: (2022)

Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy
por: Yamada, Satsuki, et al.
Publicado: (2015)

Cardio–renal–metabolic syndrome: clinical features and dapagliflozin eligibility in a real‐world heart failure cohort
por: Beles, Monika, et al.
Publicado: (2023)

Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients
por: Heggermont, Ward A., et al.
Publicado: (2020)

Cardiogenic Induction of Pluripotent Stem Cells Streamlined Through a Conserved SDF-1/VEGF/BMP2 Integrated Network
por: Chiriac, Anca, et al.
Publicado: (2010)

Developmental Enhancement of Adenylate Kinase-AMPK Metabolic Signaling Axis Supports Stem Cell Cardiac Differentiation
por: Dzeja, Petras P., et al.
Publicado: (2011)

Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome
por: Arrell, D. Kent, et al.
Publicado: (2020)

TGF-β loaded exosome enhances ischemic wound healing in vitro and in vivo
por: Shi, Ao, et al.
Publicado: (2021)

Cardiopoietic programming of embryonic stem cells for tumor-free heart repair
por: Behfar, Atta, et al.
Publicado: (2007)

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
por: Bartunek, Jozef, et al.
Publicado: (2017)

Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients
por: Treskes, Roderick W., et al.
Publicado: (2021)

Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2022)

Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients
por: Kobediona, Monika, et al.
Publicado: (2022)

Performance of non‐invasive myocardial work to predict the first hospitalization for de novo heart failure with preserved ejection fraction
por: Paolisso, Pasquale, et al.
Publicado: (2021)

In‐hospital worsening heart failure: a clinically relevant endpoint?
por: Clark, Andrew L., et al.
Publicado: (2017)

The New Heart Failure Association Definition of Advanced Heart Failure
por: Metra, Marco, et al.
Publicado: (2019)

Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial
por: Sharif, Faisal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bdnageljj3d49f1v3685a626kh